We are live on ! Find out more
LCG

Lisanti Capital Growth Portfolio holdings

AUM $455M
1-Year Est. Return 218.66%
This Fund
S&P 500
This Quarter Est. Return
+22.11%
1 Year Est. Return
+218.66%
3 Year Est. Return
+1,489.77%
5 Year Est. Return
+4,348.98%
10 Year Est. Return
+169,910.37%
AUM
$397M
AUM Growth
-$25.2M
Cap. Flow
-$55M
Cap. Flow %
-13.87%
Top 10 Hldgs %
20.66%
Holding
154
New
44
Increased
21
Reduced
38
Closed
51

Top Sells

Rank Stock Value
1
HURN icon
Huron Consulting
HURN
+$7.88M
2
ATEC icon
Alphatec Holdings
ATEC
+$7.84M
3
TMDX icon
Transmedics
TMDX
+$6.9M
4
LITE icon
Lumentum
LITE
+$6.52M
5
NAMS icon
NewAmsterdam Pharma
NAMS
+$6.29M

Sector Composition

Rank Sector Weight
1 Industrials 29.97%
2 Healthcare 23.49%
3 Technology 23.12%
4 Consumer Discretionary 10.52%
5 Energy 7.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEGA icon
101
Pegasystems
PEGA
$5.31B
$699K 0.18%
16,415
-77,111
-82% -$3.58M
LITE icon
102
Lumentum
LITE
$82.1B
$647K 0.16%
920
-11,865
-93% -$6.52M
XPO icon
103
XPO
XPO
$24.7B
$609K 0.15%
3,130
-3,110
-50% -$557K
ADMA icon
104
ADMA Biologics
ADMA
$2.12B
-83,555
Closed -$1.52M
ADPT icon
105
Adaptive Biotechnologies
ADPT
$3.94B
-142,515
Closed -$2.31M
ANF icon
106
Abercrombie & Fitch
ANF
$4.8B
-27,450
Closed -$3.46M
ANIP icon
107
ANI Pharmaceuticals
ANIP
$1.76B
-30,379
Closed -$2.4M
ATEC icon
108
Alphatec Holdings
ATEC
$1.51B
-372,407
Closed -$7.84M
BE icon
109
Bloom Energy
BE
$67.7B
-48,600
Closed -$4.22M
BJRI icon
110
BJ's Restaurants
BJRI
$1.45B
-78,870
Closed -$3.11M
BROS icon
111
Dutch Bros
BROS
$9.09B
-65,840
Closed -$4.03M
BRZE icon
112
Braze
BRZE
$3.26B
-119,030
Closed -$4.08M
CALX icon
113
Calix
CALX
$2.49B
-95,736
Closed -$5.07M
CAMT icon
114
Camtek
CAMT
$7.72B
-21,640
Closed -$2.3M
CCB icon
115
Coastal Financial
CCB
$802M
-32,609
Closed -$3.74M
CIEN icon
116
Ciena
CIEN
$60.7B
-14,145
Closed -$3.31M
CPRI icon
117
Capri Holdings
CPRI
$1.74B
-20,215
Closed -$493K
CRDO icon
118
Credo Technology Group
CRDO
$48.5B
-30,576
Closed -$4.4M
CRNX icon
119
Crinetics Pharmaceuticals
CRNX
$8.99B
-43,040
Closed -$2M
CYTK icon
120
Cytokinetics
CYTK
$10.3B
-74,200
Closed -$4.71M
DYN icon
121
Dyne Therapeutics
DYN
$4.8B
-154,445
Closed -$3.02M
EVER icon
122
EverQuote
EVER
$861M
-142,710
Closed -$3.85M
EVLV icon
123
Evolv Technologies
EVLV
$1.05B
-172,350
Closed -$1.23M
GH icon
124
Guardant Health
GH
$21.1B
-38,665
Closed -$3.95M
HRI icon
125
Herc Holdings
HRI
$5.8B
-39,060
Closed -$5.8M

Similar funds

Lisanti Capital Growth's Q1 2026 Portfolio in Review

As of Q1 2026, Lisanti Capital Growth held 154 positions worth $397M, down 6% from $422M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Lisanti Capital Growth withdrew a net $55M in Q1 2026, closing 51 positions and reducing 38 holdings. Its most notable exit was Huron Consulting, an estimated $7.88M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 30% of assets, up from 30% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Lisanti Capital Growth opened a new position in Patterson-UTI worth $9.71M.

  • Lisanti Capital Growth's largest Q1 2026 buy was Patterson-UTI: 896,470 shares worth $9.71M.
  • Lisanti Capital Growth added most to Waystar Holding Corp in Q1 2026, an estimated $4.57M increase.
  • Lisanti Capital Growth's biggest Q1 2026 reduction was Lumentum, cutting an estimated $6.52M.
  • Lisanti Capital Growth fully exited Huron Consulting in Q1 2026, selling an estimated $7.88M.
  • Lisanti Capital Growth's ten largest holdings make up 21% of its $397M portfolio in Q1 2026.
  • Lisanti Capital Growth opened 44 new positions and closed 51 in Q1 2026.
  • Lisanti Capital Growth's portfolio value fell 6% quarter-over-quarter to $397M.

Based on Lisanti Capital Growth's 13F filing for Q1 2026, filed 7 May 2026.